Robert F. Kennedy Jr., head of the Department of Health and Human Services (HHS), made his first appearance before Congress on Wednesday, testifying in both the House and Senate.
During these hearings, he faced scrutiny regarding vaccines, the cancellation of medical research, and a significant reorganization of federal health agencies as part of President Trump’s budget proposal.
Here are some key takeaways:
Clarifying Vaccine Messaging
Democratic lawmakers pressed Kennedy over his stance on vaccines.
At the center of a serious measles outbreak, he struggled to communicate the necessity of vaccination, trying to cater to both vaccine advocates and those skeptical about vaccinations.
Senator Chris Murphy (D-Conn.) challenged Kennedy on recent vaccine approval standards and his remarks concerning the measles vaccine.
“We informed the public that the vaccine’s effectiveness would wane rapidly. We approached Dr. Philshaw and stated that the measles vaccine would never undergo comprehensive safety testing. We also mentioned fetal tissue in the vaccine,” Murphy said.
“That’s all accurate!” Kennedy shot back. “Should I lie to the public?”
“That’s not factual,” Murphy countered.
Earlier, House Budget Ranking Member Rosa Delauro (D-Conn.) criticized Kennedy, suggesting he promoted misinformation.
“Currently, our nation is unprepared for diseases preventable by vaccines,” she emphasized.
When questioned by Rep. Mark Pokan (D-Wis.), Kennedy hesitated before responding, “probably.”
He had previously stated that he vaccinated his current adult children and expressed remorse for that decision.
“Honestly, my opinions on vaccines don’t matter,” he stated. “People shouldn’t look to me for medical guidance.”
Kennedy sidestepped direct questions on vaccinating children against polio or chicken pox, asserting that vaccination is ultimately a personal choice.
Addressing Organizational Changes
Kennedy passionately defended the changes at HHS.
“We had to act swiftly,” he remarked in response to a question about layoffs from Senator Andy Kim (D-N.J.). “We recognized there were some errors, and we aimed to rectify them later… but prompt action was paramount.”
Senator Lisa Murkowski (R-Alaska) inquired about delays and cuts in funding that could impact domestic violence prevention initiatives.
“As far as I know, funds for domestic violence were not reduced,” Kennedy asserted. “I’m unclear why there are delays.”
However, Murkowski noted that there might be a lack of personnel to handle such matters due to the agency’s layoffs.
Kennedy avoided specifics about HHS’s reorganization, citing court orders, but claimed that decisions to dismiss certain employees were guided by efficiency insights from Elon Musk’s Government Efficiency (DOGE) initiative.
“I had to cancel some projects,” he mentioned.
Overall, he refuted claims that many HHS offices were eliminated, suggesting that some had merely been moved to a proposed new office by the Trump administration, termed “Healthy America.”
When Rep. Lois Frankel (D-Fla.) asked about the number of HHS employees let go since January, Kennedy said around 10,000 were fired, with another 10,000 opting for voluntary resignation.
Frankel speculated, “They are being paid to do nothing.”
“Many of them should still report for duty,” Kennedy replied.
“But they’re showing up without tasks,” Frankel countered. “They have no work assignments.”
“No, no. We expect them to be productive,” Kennedy insisted.
Republicans Seeking Clarity
Republican lawmakers were also eager for insights regarding the administration’s recent changes impacting their constituents.
While not overtly questioning Kennedy’s authority, GOP members voiced concerns about various aspects of his agenda, indicating their interest in reversing harm to communities.
In the House, Republicans wanted clarity on how new regulations might affect their districts and expressed gratitude to Kennedy for reinstating some dismissed employees. They sought assurances that essential programs for their constituents would be restored.
Rep. Chuck Fleischmann (R-Tenn.) queried about the costs associated with the FDA’s initiative to eliminate artificial food dyes in products made by local manufacturers.
“I think these dyes are safe and approved, yet they’re trying to find alternatives. The expenses we estimated could skyrocket five to tenfold,” Fleischmann asked Kennedy to collaborate on the cost and safety of new dyes.
Rep. Riley Moore (R-W.Va.) pressed Kennedy to confirm that the National Institute for Occupational Safety and Health (NIOSH) employees and their programs would be fully reinstated. Numerous NIOSH employees from facilities in Moore’s area were laid off before being rehired recently.
West Virginia Republicans also aimed to guarantee the revival of both the Coal Worker Health Surveillance Program and the NIOSH ventilator approval initiative.
First Interactions with Cassidy
This marked Kennedy’s first testimony before Senator Bill Cassidy (R-La.), the chair of the Help Committee, who had previously reconsidered his support for Kennedy’s confirmation.
Cassidy eventually voted in favor of Kennedy after securing commitments from him and the Trump administration.
“We will thoroughly review our efforts to alleviate public anxieties surrounding vaccines,” Cassidy noted at that time.
However, he challenged Kennedy more forcefully during the confirmation process, especially regarding Kennedy’s longstanding claims linking vaccines to autism. On Wednesday, he adopted a gentler approach.
“Much of the narrative about the HHS agenda is shaped by unnamed sources and individuals biased against the president,” Cassidy said in his opening remarks. “Americans need reassurance from your office. The reforms need to facilitate, rather than complicate, their lives.”
On this occasion, Cassidy did not directly question Kennedy about vaccines.
At one point, he corrected Kennedy’s statement about the evaluation of vaccines, noting that some vaccines, including those for rotavirus, measles, and HPV, have undergone testing against earlier versions.
